In focus · trending topic

AbCellera Biologics Inc

1 stories · following the connections

Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies

By Nasdaq OMXFeb 2, 2016, 1:00 PM UTC